Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a study on a new low dose levonorgestrel contraceptive intrauterine systems (LCS).
The purpose of the study is to investigate which of the 2 administered doses is the lowest
effective intrauterine dose of Levonorgestrel (LNG) administered via the LCS for
contraception during 3 years. The study was amended: the LCS16 arm will be extended up to 5
years